Researchers created a comprehensive single-cell map of the tumor immune microenvironment in multiple myeloma and its precursor conditions, providing new insights that may explain why patients with similar diagnoses often have differences in disease progression, treatment response, and outcomes. The study was co-led by Robert Orlowski, M.D., Ph.D., professor of Lymphoma/Myeloma and Experimental Therapeutics; and Linghua Wang, M.D., Ph.D., professor of Genomic Medicine, executive director and head of the Center for Cellular Language Intelligence, associate...